甲状腺相关眼病彩色多普勒血流成像特点的研究
|
摘要
目的：研究甲状腺相关眼病(Thyroid-Associated Ophthalmopathy, TAO)患者眼动脉及视网膜中央动脉血流动力学特点,并结合血流参数及临床特点分析其相关性,探讨不同因素对TAO患者视网膜供血的影响。
方法：(1)应用美国GE公司生产的Logic7彩色多普勒超声诊断仪,探测49例(90只眼)明确诊断TAO且甲状腺功能正常或稳定半年以上的患者及24例(48只眼)正常对照者的眼动脉及视网膜中央动脉,记录其频谱图并测量收缩期峰值速度(PSV)、舒张末期速度(EDV)、阻力指数(RI)。(2)根据视网膜中央动脉频谱特点将TAO患者分成两组,即频谱中断组(21例,40只眼)与频谱无中断组(28例,50只眼)。(3)比较分析：分析各组血流参数之间的差别是否有统计学意义,并且分析血流参数之间及血流参数与临床特点之间的相关性。(4)统计学方法：两个样本均数的比较采用两个独立样本的非参数检验；率的比较采用2×2四格表x2检验。
结果：(1)正常对照组与TAO组比较：正常对照组OA及CRA PSV、EDV高于TAO组,RI低于正常对照组,差别均有统计学意义,P<0.05。(2)TAO组CRA频谱中断的构成比大于正常对照组,差别有统计学意义,P<0.05。(3)TAO组中,频谱中断组与频谱无中断组比较：两组OA PSV差别无统计学意义,P>0.05；频谱中断组CRA PSV低于频谱无中断组,P<0.05；频谱中断组OA及CRA EDV低于频谱无中断组,P<0.05；频谱中断组OA及CRA RI高于频谱无中断组,P<0.05。(4)正常对照组与频谱中断组比较：OA及CRA PSV、EDV均高于频谱中断组,差别有统计学意义(P<0.05)；正常对照组OA及CRA RI均低于频谱中断组,差别有统计学意义(P<0.05)。(5)正常对照组与频谱无中断组比较：两组OA PSV比较差别无统计学意义(P>0.05)；正常对照组OA EDV高于频谱无中断组,差别有统计学意义(P<0.05)；正常对照组OA RI低于频谱无中断组,差别有统计学意义(P<0.05)；正常对照组CRA PSV及EDV高于频谱无中断组,差别有统计学意义(P<0.05)；两组CRA RI差别无统计学意义(P>0.05)。(6)频谱中断组与频谱无中断组比较：两组之间眶压、眼球突出度差别有统计学意义,P<0.05；两组之间存在眼外肌肥大的构成比无明显区别,P>0.05。(7)TAO组OA PSV、EDV与眼球突出度呈负相关,P<0.05；TAO组CRA EDV与眼球突出度之间呈负相关,P<0.05；(8)TAO组OA RI与EDV存在负相关,P<0.05；TAO组CRA RI与EDV存在负相关,P<0.05。
结论：(1)在甲状腺功能正常情况下,TAO患者OA及CRA PSV、EDV较正常人下降,而RI较正常人升高。且各血流参数与眼球突出度存在一定相关性。(2)TAO患者中CRA血流频谱发生中断的比率明显高于正常对照组。(3)TAO患者中,CRA血流频谱发生中断组OA及CRA血流速度低于频谱无中断组,而RI则大于频谱无中断组。(4)TAO患者眶压增高导致OA及CRA血流参数的改变,频谱图则表现为CRA频谱出现中断,以及OA频谱较正常人变得陡峭。
Objectives:To study the hemodynamic characteristics of ophthalmic artery and central retinal artery in patients with thyroid-associated ophthalmopathy(TAO). And analyze the relevance between the blood flow parameters and the clinical characteristics.At last, discuss the different influence factors on tetinal blood supply of patients with TAO.
Methods:(1) Use the U.S. company GE's Logic7 Color Doppler Ultrasound diagnostic apparatus, to detect the ophthalmic artery and central retinal artery on 49 TAO cases (ninety eyes) whose thyroid function is normal or stable over six months and 24 normal controls (48 eyes), simultaneously, record its spectrum and measure the peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI). (2) According to the spectral characteristics of the central retinal artery, the TAO group was divided into two groups, the spectrum interruption group that include 21 patients(40 eyes) and the spectrum without interruption group that include 28 patients (50 eyes).(3) Analysis:To analyze the differences among the blood flow parameters are significant.,and analyze the correlation between the blood flow parameters and the clinical characteristics (4)Statistical Methods:The non-parametric test was used to compare the independent samples; The 2×2 tables x2 was used to compare the ratio.
Results:(1)The PSV and EDV in normal control group are higher than in TAO group,and the RI in normal group is lower than in TAO group,P<0.05.(2)The constituent ratio of the eyes whose CRA spectrum is interrupted is higher in TAO group than in normal control group, P<0.05.(3)There is no statistical significance of the OA PSV between spectrum interruption group and spectrum without interruption group,P>0.05;The CRA PSV in spectrum interruption group is lower than in spectrum without interruption group, P<0.05;The EDV of OA and CRA in spectrum interruption group is lower than in spectrum without interruption group, P<0.05; The RI of OA and CRA in spectrum interruption group is higher than in spectrum without interruption group, P<0.05.(4)Either the PSV or the EDV of OA and CRA in normal control are higher than in spectrum interruption group, P<0.05; The RI of OA and CRA in normal control are lower than in spectrum interruption group, P<0.05.(5)For the PSV of OA,there is no statistical significance between normal control group and spectrum without interruption group, P>0.05;The EDV of OA in normal control group is higher than in spectrum without interruption group, P<0.05; The RI of OA in normal control group is lower than in spectrum without interruption group, P< 0.05;The PSV and EDV of CRA in normal control group are higher than in spectrum without interruption group, P<0.05; There is no statistical significance of the CRA RI between two groups,P>0.05.(6)There is statistical significance for the differences of orbital pressure and exophthalmos between the spectrum interruption group and spectrum without interruption group; There is no statistical significance for the differences of the constituent ratio of enlarged extraocular muscle between the spectrum interruption group and spectrum without interruption group.(7)The PSV and EDV of OA tended to be negative correlated with exophthalmos, P<0.05; The EDV of CRA tended to be negative correlated with exophthalmos, P<0.05.(8)The RI of OA tended to be negative correlated with the EDV in TAO group, P<0.05; The RI of CRA tended to be negative correlated with the EDV in TAO group, P<0.05.
Conclusions:(1)Under the situation of normal thyroid function,either the PSV or the EDV of OA and CRA in TAO patients is decreased compared with normal subjects,and the RI is higher than normal subjects,and the blood flow parameters are correlated with exophthalmos.(2) The ratio of the eyes whose CRA spectrum is interrupted is higher in TAO group than in normal control group.(3)In the TAO patients,the blood flow velocity of the eyes whose CRA spectrum is interrupted is lower than the eyes whose CRA spectrum is not interrupted,but the RI is higher than the eyes whose CRA spectrum is not interrupted.(4)The increase of orbital pressure of TAO patients leads to the change of the blood flow parameters,that is the CRA spectrum is interrupted and the OA spectrum becomes steep compared with the normal subjects.
方法：(1)应用美国GE公司生产的Logic7彩色多普勒超声诊断仪,探测49例(90只眼)明确诊断TAO且甲状腺功能正常或稳定半年以上的患者及24例(48只眼)正常对照者的眼动脉及视网膜中央动脉,记录其频谱图并测量收缩期峰值速度(PSV)、舒张末期速度(EDV)、阻力指数(RI)。(2)根据视网膜中央动脉频谱特点将TAO患者分成两组,即频谱中断组(21例,40只眼)与频谱无中断组(28例,50只眼)。(3)比较分析：分析各组血流参数之间的差别是否有统计学意义,并且分析血流参数之间及血流参数与临床特点之间的相关性。(4)统计学方法：两个样本均数的比较采用两个独立样本的非参数检验；率的比较采用2×2四格表x2检验。
结果：(1)正常对照组与TAO组比较：正常对照组OA及CRA PSV、EDV高于TAO组,RI低于正常对照组,差别均有统计学意义,P<0.05。(2)TAO组CRA频谱中断的构成比大于正常对照组,差别有统计学意义,P<0.05。(3)TAO组中,频谱中断组与频谱无中断组比较：两组OA PSV差别无统计学意义,P>0.05；频谱中断组CRA PSV低于频谱无中断组,P<0.05；频谱中断组OA及CRA EDV低于频谱无中断组,P<0.05；频谱中断组OA及CRA RI高于频谱无中断组,P<0.05。(4)正常对照组与频谱中断组比较：OA及CRA PSV、EDV均高于频谱中断组,差别有统计学意义(P<0.05)；正常对照组OA及CRA RI均低于频谱中断组,差别有统计学意义(P<0.05)。(5)正常对照组与频谱无中断组比较：两组OA PSV比较差别无统计学意义(P>0.05)；正常对照组OA EDV高于频谱无中断组,差别有统计学意义(P<0.05)；正常对照组OA RI低于频谱无中断组,差别有统计学意义(P<0.05)；正常对照组CRA PSV及EDV高于频谱无中断组,差别有统计学意义(P<0.05)；两组CRA RI差别无统计学意义(P>0.05)。(6)频谱中断组与频谱无中断组比较：两组之间眶压、眼球突出度差别有统计学意义,P<0.05；两组之间存在眼外肌肥大的构成比无明显区别,P>0.05。(7)TAO组OA PSV、EDV与眼球突出度呈负相关,P<0.05；TAO组CRA EDV与眼球突出度之间呈负相关,P<0.05；(8)TAO组OA RI与EDV存在负相关,P<0.05；TAO组CRA RI与EDV存在负相关,P<0.05。
结论：(1)在甲状腺功能正常情况下,TAO患者OA及CRA PSV、EDV较正常人下降,而RI较正常人升高。且各血流参数与眼球突出度存在一定相关性。(2)TAO患者中CRA血流频谱发生中断的比率明显高于正常对照组。(3)TAO患者中,CRA血流频谱发生中断组OA及CRA血流速度低于频谱无中断组,而RI则大于频谱无中断组。(4)TAO患者眶压增高导致OA及CRA血流参数的改变,频谱图则表现为CRA频谱出现中断,以及OA频谱较正常人变得陡峭。
Objectives:To study the hemodynamic characteristics of ophthalmic artery and central retinal artery in patients with thyroid-associated ophthalmopathy(TAO). And analyze the relevance between the blood flow parameters and the clinical characteristics.At last, discuss the different influence factors on tetinal blood supply of patients with TAO.
Methods:(1) Use the U.S. company GE's Logic7 Color Doppler Ultrasound diagnostic apparatus, to detect the ophthalmic artery and central retinal artery on 49 TAO cases (ninety eyes) whose thyroid function is normal or stable over six months and 24 normal controls (48 eyes), simultaneously, record its spectrum and measure the peak systolic velocity (PSV), end diastolic velocity (EDV), resistance index (RI). (2) According to the spectral characteristics of the central retinal artery, the TAO group was divided into two groups, the spectrum interruption group that include 21 patients(40 eyes) and the spectrum without interruption group that include 28 patients (50 eyes).(3) Analysis:To analyze the differences among the blood flow parameters are significant.,and analyze the correlation between the blood flow parameters and the clinical characteristics (4)Statistical Methods:The non-parametric test was used to compare the independent samples; The 2×2 tables x2 was used to compare the ratio.
Results:(1)The PSV and EDV in normal control group are higher than in TAO group,and the RI in normal group is lower than in TAO group,P<0.05.(2)The constituent ratio of the eyes whose CRA spectrum is interrupted is higher in TAO group than in normal control group, P<0.05.(3)There is no statistical significance of the OA PSV between spectrum interruption group and spectrum without interruption group,P>0.05;The CRA PSV in spectrum interruption group is lower than in spectrum without interruption group, P<0.05;The EDV of OA and CRA in spectrum interruption group is lower than in spectrum without interruption group, P<0.05; The RI of OA and CRA in spectrum interruption group is higher than in spectrum without interruption group, P<0.05.(4)Either the PSV or the EDV of OA and CRA in normal control are higher than in spectrum interruption group, P<0.05; The RI of OA and CRA in normal control are lower than in spectrum interruption group, P<0.05.(5)For the PSV of OA,there is no statistical significance between normal control group and spectrum without interruption group, P>0.05;The EDV of OA in normal control group is higher than in spectrum without interruption group, P<0.05; The RI of OA in normal control group is lower than in spectrum without interruption group, P< 0.05;The PSV and EDV of CRA in normal control group are higher than in spectrum without interruption group, P<0.05; There is no statistical significance of the CRA RI between two groups,P>0.05.(6)There is statistical significance for the differences of orbital pressure and exophthalmos between the spectrum interruption group and spectrum without interruption group; There is no statistical significance for the differences of the constituent ratio of enlarged extraocular muscle between the spectrum interruption group and spectrum without interruption group.(7)The PSV and EDV of OA tended to be negative correlated with exophthalmos, P<0.05; The EDV of CRA tended to be negative correlated with exophthalmos, P<0.05.(8)The RI of OA tended to be negative correlated with the EDV in TAO group, P<0.05; The RI of CRA tended to be negative correlated with the EDV in TAO group, P<0.05.
Conclusions:(1)Under the situation of normal thyroid function,either the PSV or the EDV of OA and CRA in TAO patients is decreased compared with normal subjects,and the RI is higher than normal subjects,and the blood flow parameters are correlated with exophthalmos.(2) The ratio of the eyes whose CRA spectrum is interrupted is higher in TAO group than in normal control group.(3)In the TAO patients,the blood flow velocity of the eyes whose CRA spectrum is interrupted is lower than the eyes whose CRA spectrum is not interrupted,but the RI is higher than the eyes whose CRA spectrum is not interrupted.(4)The increase of orbital pressure of TAO patients leads to the change of the blood flow parameters,that is the CRA spectrum is interrupted and the OA spectrum becomes steep compared with the normal subjects.
引文
[1]Naokata Yokoyama,Shigenobu Nagataki,Masataka Uetani,et al. Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy[J].THYROID,2002,12(3):223-227.
[2]Mark F.Prummel,Martin N.Gerding,Frans W.Zonneveld, et al.The usefullness of quantitative orbital magnetic resonance imaging in Graves, ophthalmopathy[J].Clinical Endocrinology,2001,54:205-209.
[3]Bahar Yanik, Is,ik Conkbayir,Golge Acaroglu,et al. Graves'Ophthalmopathy: Comparison of the Doppler Sonography Parameters with the Activity Score[J]. JOURNAL OF CLINICAL ULTRASOUND,2005,33(8):375-380.
[4]Onur Konuk,Zafer Onaran,Suna Ozhan Oktar,et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves'orbitopathy: relation with the clinical features[J]. Graefes Arch Clin Exp Ophthalmol,2009,247:1555-1559.
[5]Mehmet Numan Alp,Ali Ozgen,Izzet Can,et al.Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation[J].Br J Ophthalmol,2000,84:1027-1030.
[6]Yasuko Kurioka, Masaaki Inaba, Takahiko Kawagishi,et al. Increased retinal blood flow in patients with Graves' disease:influence of thyroid function and ophthalmopathy [J]. European Journal of Endocrinology,2001,144:99-107.
[7]Li H,Liu YH,Li DH,et al.Value of measurements of blood flow velocity in central retinal artery in thyroid-associated ophthalmopathy[J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2004,26:460-462.
[8]罗清礼(主编).甲状腺相关眼病[M].北京,人民卫生出版社.
[9]周钢(主编).眼科多普勒技术和应用[M].昆明,云南科技出版社.
[10]Ali Ahmetog lu, Hidayet Erdo, Alimdar S,ims.ek,et al. Effect of hypertension and candesartan on the blood flow velocity of the extraocular vessels in hypertensive patients[J]. European Journal of Ultrasound,2003,16:177-182.
[11]杨漪,房勤茂，刘明瑜,等.彩色多普勒超声观测高血压眼病眼动脉血流变化[J].中国超声医学杂志,1996,12(1)：37-38.
[12]鲁一兵,缪珩,王蔚蔚.彩色多普勒血流显像对非胰岛素依赖型糖尿病 患者眼动脉血流的研究[J].南京医科大学学报(中文版),1997,17(2)：132-134.
[13]杨漪,房勤茂,刘明瑜,等.彩色多普勒超声观测青光眼眼动脉血流变化[J].中国超声医学杂志,1995,11(11)：861-863.
[14]Catherine J.Liu,Hong-Jen Chiou,Shu-Chiung Chiang,et al.Variations in ocular hemodynamics in patients with early and late glaucoma[J].Acta Ophthalmol.Scand,1999,77:658-662.
[15]Matthew D.Kay.Color Doppler Imaging in Disorders of the Orbit, Retina, and Optic Nerve[J].Seminars in Ophthalmology,1995,10(3),242-250.
[16]KENJI OHTSUKA,YASUSHI NAKAMURA.Open-angle Glaucoma Associated With Graves Disease[J]. AMERICAN JOURNAL OF OPHTHALMOLOGY,2000,129(5):613-617.
[17]Giuseppe Caruso,Marco Attard,Aurelio Caronia,et al.Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases[J]. European Journal of Radiology,2000,36:5-10.
[18]Daniela Castagnone,Toberto Tivolta,Stefania Rescalli,et al.Color Doppler Sonography in Graves'Disease:Value in Assessing Activity of Disease and Predicting Outcome[J].AJR,1996,166:203-207.
[19]Paolo Perri,Claudio Campa,Ciro Costagliola,et al.Increased Retinal Blood Flow in Patients with Active Graves'Ophthalmopathy[J].Current Eye Research,2007,32:985-990.
[20]C-C Tsai,H-C Kau,H-H Tsai,et al. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves'ophthalmopathy[J]. Eye,2006,20:1025-1029.
[21]Peter A sman. Ophthalmological evaluation in thyroid-associated ophthalmopathy[J]. ACTA OPHTHALMOLOGICA SCANDINAVICA,2003,81: 437-448.
[22]Onur Konuk,Zafer Onaran,Suna Ozhan Oktar,et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves'orbitopathy: relation with the clinical features[J]. Graefes Arch Clin Exp Ophthalmol.2009,247:1555-1559.
[23]邬宏恂.彩色多普勒超声对甲状腺相关眼病的诊断价值.中国超声医学杂 志,2005,21(7)：194-796.
[24]胡欣,刘艳君,汤文龙.彩色多普勒对Graves眼病的眼动脉血流动力学研究.华夏医学，1998，11(3)：282-283.
[25]李辉,刘玉华,李东辉,等.视网膜中央动脉血流速度测量在甲状腺相关眼病中的应用.中国医学科学院学报,2004,4：460-462.
[26]郭安民,何淑媚,陈庆,等.甲状腺机能亢进突眼征眼部生物学测值及血流动力学参数与甲状腺上动脉血流动力学相关性分析.中国超声医学杂志,2008,24(6)：31-34.
[27]李德欣,李月爱,吴瑞珍,等.彩色多普勒对甲状腺相关眼病的血流动力学研究.河北医学,2007,13(9)：1064-1066.
[28]Naokata Yokoyama,Shigenobu Nagataki,Masataka Uetani,et al. Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy[J].THYROID,2002,12(3):223-227.
[29]Jan Kvetny,Katriina Bocker Puhakka,Lisbeth Rohl,et al.Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis[J].Acta Opthalmol.Scand,2006,84:419-423.
[30]Alimgil ML,Benian O,Esgin H,et al.Ocular pulse amplitude in patients with Graves' disease: a preliminary study[J]. Acta Ophthalmol Scand,1999,77:694-696.
[31]Hartmann K,Meyer-Schwickerath R.Measurement of venous outflow pressure in the central retinal vein to evaluate intraorbital pressure in Graves' ophthalmopathy: a preliminary report[J].Strabismus,8:187-193.
[32]Matthew D. Kay. Color Doppler Imaging in Disorders of the Orbit, Retina, and Optic Nerve[J]. Seminars in Ophthalmology,1995,10(3):242-250.
[33]Mario L.R. Monteiro, Helio Angotti-Neto, Joseph E. Benabou,et al. Color Doppler Imaging of the Superior Ophthalmic Vein in Different Clinical Forms of Graves'Orbitopathy[J]. Jpn J Ophthalmol,2008,52:483-488.
[34]Saber E,McDonnell J,Zimmermann KM,et al.Extraocular muscle changes in experimental orbital venous stasis:some similarities to Graves' orbitopathy[J].Graefes Arch Clin Exp Ophthalmol,1996,234:331-336.
[35]Benning H,Lieb W,Kahaly G,et al.Color duplex ultrasound findings in patients with endocrine orbitopathy[J]. Ophthalmologe,1994,91:20-25.
[36]Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease[J]. Eye,2001,15:313-8.
[37]Naokata Yokoyama,Shigenobu Nagataki,Masataka Uetani,et al. Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy[J]. THYROID,2002,12(3):223-227.
[38]韩雪立,吴恩余.Graves眼病的CT和MRI影像学分析[J].白求恩医科大学学报,2001,27(5)：540-542.
[39]Myer EJ,Fox DL,Herdaman G,et al.Signal intensity,clinical activity and cross-sectional areas on MRI scans in thyroid eye disease[J].Eur.J Radiol,2005,56:20-24.
[40]K. Aydin,K.Guven,S. Sencer,et al. A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy[J]. Neuroradiology,2003,45:184-187.
[41]陈燕萍,林志春,沈洁,等.MRI眶内结构定量分析在Graves眼病的应用研究[J].临床放射学杂志,2007,26(4)：336-340.
[42]Yasuhiro Nishida,Suna Tian,Bengt Isberg,Et al. MRI measurements of orbital tissues in dysthyroid ophthalmopathy[J]. Graefe's Arch Clin Exp Ophthalmol,2001,239:824-831.
[43]洪庆山,薛耀明,沈洁,等.活动期Graves眼病的MRI表现与血清TSH、TRAb的特点[J].山东医药,2008,48(14)：23-24.
[44]Jan Kvetny,Katriina Bocker Puhakka,Lisbeth Rohl,et al.Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis[J].Acta Opthalmol.Scand,2006,84:419-423.
[45]N I DODDS, FRCR, MRCP. Use of high-resolution MRI of the optic nerve in Graves'Ophthalmopathy[J].The British Journal of Radiology,2009,82:541-544.
[46]毛小明,史大鹏,徐俊玲.Graves眼病的磁共振成像诊断[J].Chin Ophthal Res,1999,17(5):396-397.
[47]Suna Tian,Yasuhiro Nishida,Bengt Isberg,et al. MRI measurements of normal extraocular muscles and other orbital structures[J]. Graefe's Arch Clin Exp Ophthalmol,2000,238:393-404.
[48]段炼,李险峰,陆克义，等.99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的临床应用[J].中华眼科杂志,2006,42(12)：1068：1072.
[49]段炼,李险峰.甲状腺相关眼病与生长抑素受体显像[J].国外医学-放射医学核医学分册,2005,29(3)：108-111.
[50]Doumas AS,Krassas G,Kaltsas T,et al.Imaging somatostatin receptor activity in patients with active thyroid eye disease using.Tc-99m depreotide[J].Clin Nucl Med,2003,28(5):439-440.
[51]段炼,李险峰,胡光,等.99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的初步应用[J].山西医科大学学报,2005,36(3)：369-371.
[52]hmet Reyhan,Okan Toygar,Aysun Sukan,et al.99mTc(V)-DMSA SPECT for the assessment of disease ctivity in Graves'ophthalmopathy[J]. Nuclear Medicine Communications,2007,28:775-781.
[53]Babak Kateb, Vicky Yamamoto,Cheng Yu.Infrared thermal imaging:A review of the literature and case report[J].NeuroImage,2009,47:154-162.
[1]罗清礼(主编).甲状腺相关眼病[M].北京,人民卫生出版社.
[2]宋国祥(主编).现代眼科影像学[M].天津,天津科学技术出版社,37.
[3]李华,王滨,王振常,曹庆选(主编).眼科影像学[M].北京,人民卫生出版社,462-464.
[4]方海珍,李乐平.正常人眼外肌厚度的标准化A超测量[J].眼视光学杂] 志,2006,8(3)：186-188.
[5]Prummel MF,Syttorp-Schulten MSA,Wiersinga,et al.A new ultrasonic method to detect disease activity and predict response to immunosuppressive treatment in Graves'ophthalmopathy[J]. Ophthalmology,1991,100:556-61.
[6]Hans C,Fledelius,Tina Zimmermann-Belsing,Ulla feldt-Tasmussen.Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy:cross-section and longitudinal aspects in a Danish series[J].Acta Ophthalmol.Scand,2003,81:143-150.
[7]邬宏恂.彩色多普勒超声对甲状腺相关眼病的诊断价值.中国超声医学杂志[J],2005,21(7)：194-796.
[8]胡欣,刘艳君,汤文龙.彩色多普勒对Graves眼病的眼动脉血流动力学研究[J].华夏医学,1998,11(3)：282-283.
[9]Bahar Yanik, Is,ik Conkbayir,Golge Acaroglu,et al. Graves'Ophthalmopathy: Comparison of the Doppler Sonography Parameters with the Activity Score[J]. JOURNAL OF CLINICAL ULTRASOUND,2005,33(8):375-380.
[10]Mehmet Numan Alp,Ali Ozgen,Izzet Can,et al.Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation[J].Br J Ophthalmol,2000,84:1027-1030.
[11]C-C Tsail,H-C Kau,H-H Tsai,et al. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves'ophthalmopathy[J]. Eye,2006,20:1025-1029.
[12]Onur Konuk,Zafer Onaran,Suna Ozhan Oktar,et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves'orbitopathy: relation with the clinical features[J]. Graefes Arch Clin Exp Ophthalmol,2009,247:1555-1559.
[13]李勤,童南伟,梁荩忠.44例Graves眼病临床与CT扫描分析[J].华西医学,1995,10(4)：407-409.
[14]吕红彬,黄新文,罗清礼,等.CT在甲状腺相关眼病中的诊断价值[J].四川大学学报,2007,38(1)：167-169.
[15]方志平.Graves眼病的CT诊断讨论[J].中国综合临床,2000，16(2)：140-14.
[16]A OZGEN,M N ALP,M ARIYUREK.et al.Quantitative CT of the orbit in Graves' disease.The British Journal of Radiology[J],1999,72:757-762.
[17]Uhlenbrock D.Computed tomography in Graves, ophthalmopathy-evaluation regarding the muscle size and density units.Neurosury Rev[J],1988,11:45-51.
[18]赵毅凯,杨振海,尹智.定量眼眶冠状位CT测量在甲状腺相关眼病中的应用[J].实用放射学杂志,2008,24(12)：1604-1606.
[19]杨振海,赵毅凯,尹智,等.甲状腺相关性眼病CT影像学定量分析[J].临床放射学杂志,2009,28(3)：310-313.
[20]Guy J.Ben Simon,Hasan M.Syed,Raymond Douglas,et al.Extraocular Muscle Enlargement with Tendon Involvement in Thyroid-associated Orbitopathy[J].Am J Ophthalmol.2004,137:1145-1147.
[21]杨振海,赵毅凯,尹智,等.甲状腺相关性眼病眼球突出CT影像分析[J].中国实用眼科杂志,2008,26(8)：837-839.
[22]Nishida Y, Tian S, Isberg B, et al. Significance of orbital fatty tissue for exophthalmos in thyroid2associated ophthalmopathy[J]Graefe's Arch Clin Exp Ophthalmol,2002,240:515.
[23]侯国富.Graves眼病：CT征象及其与临床体征的相关性研究[J].实用放射学杂志,2008,24(2)：158-160.
[24]L.-L. Chan,H.-E. Tan,S. Fook-Chong,et al.Graves Ophthalmopathy: The Bony Orbit in Optic Neuropathy, Its Apical Angular Capacity, and Impact on Prediction of Risk[J]. AJNR Am J Neuroradiol,2009,30:597-602.
[25]Mark F.Prummel,Martin N.Gerding,Frans W.Zonneveld, et al.The usefullness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy[J].Clinical Endocrinology,2001,54:205-209.
[26]M J FIRBANK,A COULTHARD,FRCR.Evaluation of a technique for estimation of extraocular muscle volume using 2D MRI[J]. The British Journal of Radiology,2000,73:1282-1289.
[27]Claridge KG, Ghabrial R, Davis G, et al. Combined radiotherapy and immunosuppression in the management of thyroid eye disease[J].Eye,1997;11:717-22.
[28]Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease[J]. Eye,2001,15:313-8.
[29]Naokata Yokoyama,Shigenobu Nagataki,Masataka Uetani,et al. Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy[J].THYROID,2002,12(3):223-227.
[30]韩雪立,吴恩余.Graves眼病的CT和MRI影像学分析[J].白求恩医科大学学报,2001,27(5)：540-542.
[31]Myer EJ,Fox DL,Herdaman Qet al.Signal intensity,clinical activity and cross-sectional areas on MRI scans in thyroid eye disease[J].Eur.J Radiol,2005,56:20-24.
[32]K. Aydin,K.Guven,S. Sencer,et al. A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy[J]. Neuroradiology,2003,45:184-187.
[33]陈燕萍,林志春,沈洁,等.MRI眶内结构定量分析在Graves眼病的应用研究[J].临床放射学杂志,2007,26(4)：336-340.
[34]Yasuhiro Nishida,Suna Tian,Bengt Isberg,Et al. MRI measurements of orbital tissues in dysthyroid ophthalmopathy[J]. Graefe's Arch Clin Exp Ophthalmol,2001,239:824-831.
[35]洪庆山,薛耀明,沈洁,等.活动期Graves眼病的MRI表现与血清TSH、TRAb的特点[J].山东医药,2008,48(14)：23-24.
[36]Jan Kvetny,Katriina Bocker Puhakka,Lisbeth Rohl,et al.Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis[J].Acta Opthalmol.Scand,2006,84:419-423.
[37]N I DODDS, FRCR, MRCP. Use of high-resolution MRI of the optic nerve in Graves'Ophthalmopathy[J].The British Journal of Radiology,2009,82:541-544.
[38]毛小明,史大鹏,徐俊玲.Graves眼病的磁共振成像诊断[J].Chin Ophthal Res,1999,17(5):396-397.
[39]Suna Tian,Yasuhiro Nishida,Bengt Isberg,et al. MRI measurements of normal extraocular muscles and other orbital structures[J]. Graefe's Arch Clin Exp Ophthalmol,2000,238:393-404.
[40]段炼,李险峰,陆克义，等.99 Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的临 床应用[J].中华眼科杂志,2006,42(12)：1068：1072.
[41]段炼,李险峰.甲状腺相关眼病与生长抑素受体显像[J].国外医学-放射医学核医学分册,2005,29(3)：108-111.
[42]Doumas AS,Krassas G,Kaltsas T,et al.Imaging somatostatin receptor activity in patients with active thyroid eye disease using.Tc-99m depreotide[J].Clin Nucl Med,2003,28(5):439-440.
[43]段炼,李险峰,胡光，等.99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的初步应用[J].山西医科大学学报,2005,36(3)：369-371.
[44]hmet Reyhan,Okan Toygar,Aysun Sukan,et al.99mTc(V)-DMSA SPECT for the assessment of disease ctivity in Graves'ophthalmopathy[J]. Nuclear Medicine Communications,2007,28:775-781.
[45]Babak Kateb, Vicky Yamamoto,Cheng Yu.Infrared thermal imaging:A review of the literature and case report[J].NeuroImage,2009,47:154-162.
[46]Tien-Chun Chang,Yung-Lien Hsiao,Shu-Lang Liao. Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect mof methylprednisolone pulse therapy in patients with Graves' ophthalmopathy.Graefes Arch Clin Exp Ophthalmol[J],2008,246:45-49.
[47]Demer JL,Kerman BM.comparison of standardized echography with magnetic resonance imaging to measure extraocular muscle size[J].Am J Ophthalmol,1994,118:351-361.
[48]Dick AD, Nangia V, Atta H.Standardised echography in the differential diagnosis of extraocular muscle enlargement[J]. Eye,1992,6:610-617.
[49]Ossoinig KC Ultrasonic diagnosis of Graves'ophthalmopathy. In: Gorman CA (ed) The eye and orbit in thyroid disease[J]. Raven Press,1984,185-211.
[2]Mark F.Prummel,Martin N.Gerding,Frans W.Zonneveld, et al.The usefullness of quantitative orbital magnetic resonance imaging in Graves, ophthalmopathy[J].Clinical Endocrinology,2001,54:205-209.
[3]Bahar Yanik, Is,ik Conkbayir,Golge Acaroglu,et al. Graves'Ophthalmopathy: Comparison of the Doppler Sonography Parameters with the Activity Score[J]. JOURNAL OF CLINICAL ULTRASOUND,2005,33(8):375-380.
[4]Onur Konuk,Zafer Onaran,Suna Ozhan Oktar,et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves'orbitopathy: relation with the clinical features[J]. Graefes Arch Clin Exp Ophthalmol,2009,247:1555-1559.
[5]Mehmet Numan Alp,Ali Ozgen,Izzet Can,et al.Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation[J].Br J Ophthalmol,2000,84:1027-1030.
[6]Yasuko Kurioka, Masaaki Inaba, Takahiko Kawagishi,et al. Increased retinal blood flow in patients with Graves' disease:influence of thyroid function and ophthalmopathy [J]. European Journal of Endocrinology,2001,144:99-107.
[7]Li H,Liu YH,Li DH,et al.Value of measurements of blood flow velocity in central retinal artery in thyroid-associated ophthalmopathy[J].Zhongguo Yi Xue Ke Xue Yuan Xue Bao,2004,26:460-462.
[8]罗清礼(主编).甲状腺相关眼病[M].北京,人民卫生出版社.
[9]周钢(主编).眼科多普勒技术和应用[M].昆明,云南科技出版社.
[10]Ali Ahmetog lu, Hidayet Erdo, Alimdar S,ims.ek,et al. Effect of hypertension and candesartan on the blood flow velocity of the extraocular vessels in hypertensive patients[J]. European Journal of Ultrasound,2003,16:177-182.
[11]杨漪,房勤茂，刘明瑜,等.彩色多普勒超声观测高血压眼病眼动脉血流变化[J].中国超声医学杂志,1996,12(1)：37-38.
[12]鲁一兵,缪珩,王蔚蔚.彩色多普勒血流显像对非胰岛素依赖型糖尿病 患者眼动脉血流的研究[J].南京医科大学学报(中文版),1997,17(2)：132-134.
[13]杨漪,房勤茂,刘明瑜,等.彩色多普勒超声观测青光眼眼动脉血流变化[J].中国超声医学杂志,1995,11(11)：861-863.
[14]Catherine J.Liu,Hong-Jen Chiou,Shu-Chiung Chiang,et al.Variations in ocular hemodynamics in patients with early and late glaucoma[J].Acta Ophthalmol.Scand,1999,77:658-662.
[15]Matthew D.Kay.Color Doppler Imaging in Disorders of the Orbit, Retina, and Optic Nerve[J].Seminars in Ophthalmology,1995,10(3),242-250.
[16]KENJI OHTSUKA,YASUSHI NAKAMURA.Open-angle Glaucoma Associated With Graves Disease[J]. AMERICAN JOURNAL OF OPHTHALMOLOGY,2000,129(5):613-617.
[17]Giuseppe Caruso,Marco Attard,Aurelio Caronia,et al.Color Doppler measurement of blood flow in the inferior thyroid artery in patients with autoimmune thyroid diseases[J]. European Journal of Radiology,2000,36:5-10.
[18]Daniela Castagnone,Toberto Tivolta,Stefania Rescalli,et al.Color Doppler Sonography in Graves'Disease:Value in Assessing Activity of Disease and Predicting Outcome[J].AJR,1996,166:203-207.
[19]Paolo Perri,Claudio Campa,Ciro Costagliola,et al.Increased Retinal Blood Flow in Patients with Active Graves'Ophthalmopathy[J].Current Eye Research,2007,32:985-990.
[20]C-C Tsai,H-C Kau,H-H Tsai,et al. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves'ophthalmopathy[J]. Eye,2006,20:1025-1029.
[21]Peter A sman. Ophthalmological evaluation in thyroid-associated ophthalmopathy[J]. ACTA OPHTHALMOLOGICA SCANDINAVICA,2003,81: 437-448.
[22]Onur Konuk,Zafer Onaran,Suna Ozhan Oktar,et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves'orbitopathy: relation with the clinical features[J]. Graefes Arch Clin Exp Ophthalmol.2009,247:1555-1559.
[23]邬宏恂.彩色多普勒超声对甲状腺相关眼病的诊断价值.中国超声医学杂 志,2005,21(7)：194-796.
[24]胡欣,刘艳君,汤文龙.彩色多普勒对Graves眼病的眼动脉血流动力学研究.华夏医学，1998，11(3)：282-283.
[25]李辉,刘玉华,李东辉,等.视网膜中央动脉血流速度测量在甲状腺相关眼病中的应用.中国医学科学院学报,2004,4：460-462.
[26]郭安民,何淑媚,陈庆,等.甲状腺机能亢进突眼征眼部生物学测值及血流动力学参数与甲状腺上动脉血流动力学相关性分析.中国超声医学杂志,2008,24(6)：31-34.
[27]李德欣,李月爱,吴瑞珍,等.彩色多普勒对甲状腺相关眼病的血流动力学研究.河北医学,2007,13(9)：1064-1066.
[28]Naokata Yokoyama,Shigenobu Nagataki,Masataka Uetani,et al. Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy[J].THYROID,2002,12(3):223-227.
[29]Jan Kvetny,Katriina Bocker Puhakka,Lisbeth Rohl,et al.Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis[J].Acta Opthalmol.Scand,2006,84:419-423.
[30]Alimgil ML,Benian O,Esgin H,et al.Ocular pulse amplitude in patients with Graves' disease: a preliminary study[J]. Acta Ophthalmol Scand,1999,77:694-696.
[31]Hartmann K,Meyer-Schwickerath R.Measurement of venous outflow pressure in the central retinal vein to evaluate intraorbital pressure in Graves' ophthalmopathy: a preliminary report[J].Strabismus,8:187-193.
[32]Matthew D. Kay. Color Doppler Imaging in Disorders of the Orbit, Retina, and Optic Nerve[J]. Seminars in Ophthalmology,1995,10(3):242-250.
[33]Mario L.R. Monteiro, Helio Angotti-Neto, Joseph E. Benabou,et al. Color Doppler Imaging of the Superior Ophthalmic Vein in Different Clinical Forms of Graves'Orbitopathy[J]. Jpn J Ophthalmol,2008,52:483-488.
[34]Saber E,McDonnell J,Zimmermann KM,et al.Extraocular muscle changes in experimental orbital venous stasis:some similarities to Graves' orbitopathy[J].Graefes Arch Clin Exp Ophthalmol,1996,234:331-336.
[35]Benning H,Lieb W,Kahaly G,et al.Color duplex ultrasound findings in patients with endocrine orbitopathy[J]. Ophthalmologe,1994,91:20-25.
[36]Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease[J]. Eye,2001,15:313-8.
[37]Naokata Yokoyama,Shigenobu Nagataki,Masataka Uetani,et al. Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy[J]. THYROID,2002,12(3):223-227.
[38]韩雪立,吴恩余.Graves眼病的CT和MRI影像学分析[J].白求恩医科大学学报,2001,27(5)：540-542.
[39]Myer EJ,Fox DL,Herdaman G,et al.Signal intensity,clinical activity and cross-sectional areas on MRI scans in thyroid eye disease[J].Eur.J Radiol,2005,56:20-24.
[40]K. Aydin,K.Guven,S. Sencer,et al. A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy[J]. Neuroradiology,2003,45:184-187.
[41]陈燕萍,林志春,沈洁,等.MRI眶内结构定量分析在Graves眼病的应用研究[J].临床放射学杂志,2007,26(4)：336-340.
[42]Yasuhiro Nishida,Suna Tian,Bengt Isberg,Et al. MRI measurements of orbital tissues in dysthyroid ophthalmopathy[J]. Graefe's Arch Clin Exp Ophthalmol,2001,239:824-831.
[43]洪庆山,薛耀明,沈洁,等.活动期Graves眼病的MRI表现与血清TSH、TRAb的特点[J].山东医药,2008,48(14)：23-24.
[44]Jan Kvetny,Katriina Bocker Puhakka,Lisbeth Rohl,et al.Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis[J].Acta Opthalmol.Scand,2006,84:419-423.
[45]N I DODDS, FRCR, MRCP. Use of high-resolution MRI of the optic nerve in Graves'Ophthalmopathy[J].The British Journal of Radiology,2009,82:541-544.
[46]毛小明,史大鹏,徐俊玲.Graves眼病的磁共振成像诊断[J].Chin Ophthal Res,1999,17(5):396-397.
[47]Suna Tian,Yasuhiro Nishida,Bengt Isberg,et al. MRI measurements of normal extraocular muscles and other orbital structures[J]. Graefe's Arch Clin Exp Ophthalmol,2000,238:393-404.
[48]段炼,李险峰,陆克义，等.99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的临床应用[J].中华眼科杂志,2006,42(12)：1068：1072.
[49]段炼,李险峰.甲状腺相关眼病与生长抑素受体显像[J].国外医学-放射医学核医学分册,2005,29(3)：108-111.
[50]Doumas AS,Krassas G,Kaltsas T,et al.Imaging somatostatin receptor activity in patients with active thyroid eye disease using.Tc-99m depreotide[J].Clin Nucl Med,2003,28(5):439-440.
[51]段炼,李险峰,胡光,等.99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的初步应用[J].山西医科大学学报,2005,36(3)：369-371.
[52]hmet Reyhan,Okan Toygar,Aysun Sukan,et al.99mTc(V)-DMSA SPECT for the assessment of disease ctivity in Graves'ophthalmopathy[J]. Nuclear Medicine Communications,2007,28:775-781.
[53]Babak Kateb, Vicky Yamamoto,Cheng Yu.Infrared thermal imaging:A review of the literature and case report[J].NeuroImage,2009,47:154-162.
[1]罗清礼(主编).甲状腺相关眼病[M].北京,人民卫生出版社.
[2]宋国祥(主编).现代眼科影像学[M].天津,天津科学技术出版社,37.
[3]李华,王滨,王振常,曹庆选(主编).眼科影像学[M].北京,人民卫生出版社,462-464.
[4]方海珍,李乐平.正常人眼外肌厚度的标准化A超测量[J].眼视光学杂] 志,2006,8(3)：186-188.
[5]Prummel MF,Syttorp-Schulten MSA,Wiersinga,et al.A new ultrasonic method to detect disease activity and predict response to immunosuppressive treatment in Graves'ophthalmopathy[J]. Ophthalmology,1991,100:556-61.
[6]Hans C,Fledelius,Tina Zimmermann-Belsing,Ulla feldt-Tasmussen.Ultrasonically measured horizontal eye muscle thickness in thyroid associated orbitopathy:cross-section and longitudinal aspects in a Danish series[J].Acta Ophthalmol.Scand,2003,81:143-150.
[7]邬宏恂.彩色多普勒超声对甲状腺相关眼病的诊断价值.中国超声医学杂志[J],2005,21(7)：194-796.
[8]胡欣,刘艳君,汤文龙.彩色多普勒对Graves眼病的眼动脉血流动力学研究[J].华夏医学,1998,11(3)：282-283.
[9]Bahar Yanik, Is,ik Conkbayir,Golge Acaroglu,et al. Graves'Ophthalmopathy: Comparison of the Doppler Sonography Parameters with the Activity Score[J]. JOURNAL OF CLINICAL ULTRASOUND,2005,33(8):375-380.
[10]Mehmet Numan Alp,Ali Ozgen,Izzet Can,et al.Colour Doppler imaging of the orbital vasculature in Graves' disease with computed tomographic correlation[J].Br J Ophthalmol,2000,84:1027-1030.
[11]C-C Tsail,H-C Kau,H-H Tsai,et al. Pulsatile ocular blood flow change after treatment with systemic steroid in patients with Graves'ophthalmopathy[J]. Eye,2006,20:1025-1029.
[12]Onur Konuk,Zafer Onaran,Suna Ozhan Oktar,et al. Intraocular pressure and superior ophthalmic vein blood flow velocity in Graves'orbitopathy: relation with the clinical features[J]. Graefes Arch Clin Exp Ophthalmol,2009,247:1555-1559.
[13]李勤,童南伟,梁荩忠.44例Graves眼病临床与CT扫描分析[J].华西医学,1995,10(4)：407-409.
[14]吕红彬,黄新文,罗清礼,等.CT在甲状腺相关眼病中的诊断价值[J].四川大学学报,2007,38(1)：167-169.
[15]方志平.Graves眼病的CT诊断讨论[J].中国综合临床,2000，16(2)：140-14.
[16]A OZGEN,M N ALP,M ARIYUREK.et al.Quantitative CT of the orbit in Graves' disease.The British Journal of Radiology[J],1999,72:757-762.
[17]Uhlenbrock D.Computed tomography in Graves, ophthalmopathy-evaluation regarding the muscle size and density units.Neurosury Rev[J],1988,11:45-51.
[18]赵毅凯,杨振海,尹智.定量眼眶冠状位CT测量在甲状腺相关眼病中的应用[J].实用放射学杂志,2008,24(12)：1604-1606.
[19]杨振海,赵毅凯,尹智,等.甲状腺相关性眼病CT影像学定量分析[J].临床放射学杂志,2009,28(3)：310-313.
[20]Guy J.Ben Simon,Hasan M.Syed,Raymond Douglas,et al.Extraocular Muscle Enlargement with Tendon Involvement in Thyroid-associated Orbitopathy[J].Am J Ophthalmol.2004,137:1145-1147.
[21]杨振海,赵毅凯,尹智,等.甲状腺相关性眼病眼球突出CT影像分析[J].中国实用眼科杂志,2008,26(8)：837-839.
[22]Nishida Y, Tian S, Isberg B, et al. Significance of orbital fatty tissue for exophthalmos in thyroid2associated ophthalmopathy[J]Graefe's Arch Clin Exp Ophthalmol,2002,240:515.
[23]侯国富.Graves眼病：CT征象及其与临床体征的相关性研究[J].实用放射学杂志,2008,24(2)：158-160.
[24]L.-L. Chan,H.-E. Tan,S. Fook-Chong,et al.Graves Ophthalmopathy: The Bony Orbit in Optic Neuropathy, Its Apical Angular Capacity, and Impact on Prediction of Risk[J]. AJNR Am J Neuroradiol,2009,30:597-602.
[25]Mark F.Prummel,Martin N.Gerding,Frans W.Zonneveld, et al.The usefullness of quantitative orbital magnetic resonance imaging in Graves' ophthalmopathy[J].Clinical Endocrinology,2001,54:205-209.
[26]M J FIRBANK,A COULTHARD,FRCR.Evaluation of a technique for estimation of extraocular muscle volume using 2D MRI[J]. The British Journal of Radiology,2000,73:1282-1289.
[27]Claridge KG, Ghabrial R, Davis G, et al. Combined radiotherapy and immunosuppression in the management of thyroid eye disease[J].Eye,1997;11:717-22.
[28]Mayer E, Herdman G, Burnett C, Kabala J, Goddard P, Potts MJ. Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease[J]. Eye,2001,15:313-8.
[29]Naokata Yokoyama,Shigenobu Nagataki,Masataka Uetani,et al. Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy[J].THYROID,2002,12(3):223-227.
[30]韩雪立,吴恩余.Graves眼病的CT和MRI影像学分析[J].白求恩医科大学学报,2001,27(5)：540-542.
[31]Myer EJ,Fox DL,Herdaman Qet al.Signal intensity,clinical activity and cross-sectional areas on MRI scans in thyroid eye disease[J].Eur.J Radiol,2005,56:20-24.
[32]K. Aydin,K.Guven,S. Sencer,et al. A new MRI method for the quantitative evaluation of extraocular muscle size in thyroid ophthalmopathy[J]. Neuroradiology,2003,45:184-187.
[33]陈燕萍,林志春,沈洁,等.MRI眶内结构定量分析在Graves眼病的应用研究[J].临床放射学杂志,2007,26(4)：336-340.
[34]Yasuhiro Nishida,Suna Tian,Bengt Isberg,Et al. MRI measurements of orbital tissues in dysthyroid ophthalmopathy[J]. Graefe's Arch Clin Exp Ophthalmol,2001,239:824-831.
[35]洪庆山,薛耀明,沈洁,等.活动期Graves眼病的MRI表现与血清TSH、TRAb的特点[J].山东医药,2008,48(14)：23-24.
[36]Jan Kvetny,Katriina Bocker Puhakka,Lisbeth Rohl,et al.Magnetic resonance imaging determination of extraocular eye muscle volume in patients with thyroid-associated ophthalmopathy and proptosis[J].Acta Opthalmol.Scand,2006,84:419-423.
[37]N I DODDS, FRCR, MRCP. Use of high-resolution MRI of the optic nerve in Graves'Ophthalmopathy[J].The British Journal of Radiology,2009,82:541-544.
[38]毛小明,史大鹏,徐俊玲.Graves眼病的磁共振成像诊断[J].Chin Ophthal Res,1999,17(5):396-397.
[39]Suna Tian,Yasuhiro Nishida,Bengt Isberg,et al. MRI measurements of normal extraocular muscles and other orbital structures[J]. Graefe's Arch Clin Exp Ophthalmol,2000,238:393-404.
[40]段炼,李险峰,陆克义，等.99 Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的临 床应用[J].中华眼科杂志,2006,42(12)：1068：1072.
[41]段炼,李险峰.甲状腺相关眼病与生长抑素受体显像[J].国外医学-放射医学核医学分册,2005,29(3)：108-111.
[42]Doumas AS,Krassas G,Kaltsas T,et al.Imaging somatostatin receptor activity in patients with active thyroid eye disease using.Tc-99m depreotide[J].Clin Nucl Med,2003,28(5):439-440.
[43]段炼,李险峰,胡光，等.99Tcm-奥曲肽眼眶显像在甲状腺相关眼病中的初步应用[J].山西医科大学学报,2005,36(3)：369-371.
[44]hmet Reyhan,Okan Toygar,Aysun Sukan,et al.99mTc(V)-DMSA SPECT for the assessment of disease ctivity in Graves'ophthalmopathy[J]. Nuclear Medicine Communications,2007,28:775-781.
[45]Babak Kateb, Vicky Yamamoto,Cheng Yu.Infrared thermal imaging:A review of the literature and case report[J].NeuroImage,2009,47:154-162.
[46]Tien-Chun Chang,Yung-Lien Hsiao,Shu-Lang Liao. Application of digital infrared thermal imaging in determining inflammatory state and follow-up effect mof methylprednisolone pulse therapy in patients with Graves' ophthalmopathy.Graefes Arch Clin Exp Ophthalmol[J],2008,246:45-49.
[47]Demer JL,Kerman BM.comparison of standardized echography with magnetic resonance imaging to measure extraocular muscle size[J].Am J Ophthalmol,1994,118:351-361.
[48]Dick AD, Nangia V, Atta H.Standardised echography in the differential diagnosis of extraocular muscle enlargement[J]. Eye,1992,6:610-617.
[49]Ossoinig KC Ultrasonic diagnosis of Graves'ophthalmopathy. In: Gorman CA (ed) The eye and orbit in thyroid disease[J]. Raven Press,1984,185-211.